Protein-protein interactions in Cdk5 regulation and function

NeuroSignals

Volumn 12, Issue 4-5, 2003, Pages 230-238

  Lim, Anthony C B ^a   Qu, Dianbo ^a   Qi, Robert Z ^b  

^a INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

^b HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

Author keywords

Cdk5; Cdk5 activator; Cdk5 inhibitor; Cdk5 substrate phosphorylation; Protein protein interaction, Cdk5 regulation function

Indexed keywords

CYCLIN DEPENDENT KINASE 5; PROTEIN P35; REGULATOR PROTEIN;

BRAIN; CENTRAL NERVOUS SYSTEM; CYTOSKELETON; FOCAL ADHESION; MICROTUBULE; NERVE CELL; NONHUMAN; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; REVIEW; SYNAPSE;

ANIMALS; BINDING SITES; CYCLIN-DEPENDENT KINASE 5; CYCLIN-DEPENDENT KINASES; ENZYME ACTIVATION; MOLECULAR BIOLOGY; NERVE TISSUE PROTEINS; PHOSPHORYLATION; PROTEIN BINDING;

EID: 0346119139     PISSN: 1424862X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000074625     Document Type: Review

References (104)

1. Cohen P: The origins of protein phosphorylation. Nat Cell Biol 2002;4:E127-E130.
2. Hunter T: Signaling -2000 and beyond. Cell 2000;100:113-127.
3. Tannoch VJ, Hinds PW, Tsai LH: Cell cycle control. Adv Exp Med Biol 2000;465:127-140.
4. Morgan DO: Cyclin-dependent kinases: Engines, clocks, and microprocessors. Annu Rev Cell Dev Biol 1997;13:261-291.
5. Li A, Blow JJ: The origin of CDK regulation. Nat Cell Biol 2001;3:E182-E184.
6. Lew J, Beaudette K, Litwin CM, Wang JH: Purification and characterization of a novel proline-directed protein kinase from bovine brain. J Biol Chem 1992;267:13383-13390.
7. Meyerson M, Enders GH, Wu CL, Su LK, Gorka C, Nelson C, Harlow E, Tsai LH: A family of human cdc2-related protein kinases. EMBO J 1992;11:2909-2917.
8. Xiong Y, Zhang H, Beach D: D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 1992;71:505-514.
9. Miyajima M, Nornes HO, Neuman T: Cyclin E is expressed in neurons and forms complexes with cdk5. Neuroreport 1995;6:1130-1132.
10. Lew J, Huang QQ, Qi Z, Winkfein RJ, Aebersold R, Hunt T, Wang JH: A brain-specific activator of cyclin-dependent kinase 5. Nature 1994;371:423-426.
11. Zheng M, Leung CL, Liem RK: Region-specific expression of cyclin-dependent kinase 5 (cdk5) and its activators, p35 and p39, in the developing and adult rat central nervous system. J Neurobiol 1998;35:141-159.
12. Qi Z, Huang QQ, Lee KY, Lew J, Wang JH: Reconstitution of neuronal Cdc2-like kinase from bacteria-expressed Cdk5 and an active fragment of the brain-specific activator: Kinase activation in the absence of Cdk5 phosphorylation. J Biol Chem 1995;270:10847-10854.
13. Tang D, Yeung J, Lee KY, Matsushita M, Matsui H, Tomizawa K, Hatase O, Wang JH: An isoform of the neuronal cyclin-dependent kinase 5 (Cdk5) activator. J Biol Chem 1995;270:26897-26903.
14. Humbert S, Dhavan R, Tsai L: p39 activates cdk5 in neurons and is associated with the actin cytoskeleton. J Cell Sci 2000;113:975-983.
15. Tsai LH, Delalle I, Caviness VS, Chae T, Harlow E: p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5. Nature 1994;371:419-423.
16. Ishiguro K, Kobayashi S, Omori A, Takamatsu M, Yonekura S, Anzai K, Imahori K, Uchida T: Identification of the 23 kDa subunit of tau protein kinase II as a putative activator of cdk5 in bovine brain. FEBS Lett 1994;342:203-208.
17. Ko J, Humbert S, Bronson RT, Takahashi S, Kulkarni AB, Li E, Tsai LH: p35 and p39 are essential for cyclin-dependent kinase 5 function during neurodevelopment. J Neurosci 2001;21:6758-6771.
18. Homayouni R, Curran T: Cortical development: Cdk5 gets into sticky situations. Curr Biol 2000;10:R331-R334.
19. Dhavan R, Tsai LH: A decade of CDK5. Nat Rev Mol Cell Biol 2001;2:749-759.
20. Ohshima T, Ward JM, Huh CG, Longenecker G, Veeranna Ohshima T, Pant HC, Brady RO, Martin LJ, Kulkarni AB: Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death. Proc Natl Acad Sci USA 1996;93:11173-11178.
21. Gilmore EC, Ohshima T, Goffinet AM, Kulkarni AB, Herrup K: Cyclin-dependent kinase 5-deficient mice demonstrate novel developmental arrest in cerebral cortex. J Neurosci 1998;18:6370-6377.
22. Ohshima T, Gilmore EC, Longenecker G, Jacobowitz DM, Brady RO, Herrup K, Kulkarni AB: Migration defects of cdk5(-/-) neurons in the developing cerebellum is cell autonomous. J Neurosci 1999;19:6017-6026.
23. Tanaka T, Veeranna Ohshima T, Rajan P, Amin ND, Cho A, Sreenath T, Pant HC, Brady RO, Kulkarni AB: Neuronal cyclin-dependent kinase 5 activity is critical for survival. J Neurosci 2001;21:550-558.
24. Chae T, Kwon YT, Bronson R, Dikkes P, Li E, Tsai LH: Mice lacking p35, a neuronal specific activator of Cdk5, display cortical lamination defects, seizures, and adult lethality. Neuron 1997;18:29-42.
25. Kwon YT, Tsai LH: A novel disruption of cortical development in p35(-/-) mice distinct from reeler. J Comp Neurol 1998;395:510-522.
26. Lee KY, Rosales JL, Tang D, Wang JH: Interaction of cyclin-dependent kinase 5 (Cdk5) and neuronal Cdk5 activator in bovine brain. J Biol Chem 1996;271:1538-1543.
27. Rosales JL, Nodwell MJ, Johnston RN, Lee KY: Cdk5/p25(nck5a) interaction with synaptic proteins in bovine brain. J Cell Biochem 2000;78:151-159.
28. Delalle I, Bhide PG, Caviness VS, Tsai LH: Temporal and spatial patterns of expression of p35, a regulatory subunit of cyclin-dependent kinase 5, in the nervous system of the mouse. J Neurocytol 1997;26:283-296.
29. nck5a activity. J Biol Chem 2002;277:7324-7332.
30. Patrick GN, Zukerberg L, Nikolic M, de La Monte S, Dikkes P, Tsai LH: Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 1999;402:615-622.
31. Patzke H, Tsai LH: Calpain-mediated cleavage of the cyclin-dependent kinase-5 activator p39 to p29. J Biol Chem 2002;277:8054-8060.
32. Paglini G, Peris L, Diez-Guerra J, Quiroga S, Caceres A: The Cdk5-p35 kinase associates with the Golgi apparatus and regulates membrane traffic. EMBO Rep 2001;2:1139-1144.
33. Kusakawa G, Saito T, Onuki R, Ishiguro K, Kishimoto T, Hisanaga S: Calpain-dependent proteolytic cleavage of the p35 cyclin-dependent kinase 5 activator to p25. J Biol Chem 2000;275:17166-17172.
34. Lee MS, Kwon YT, Li M, Peng J, Friedlander RM, Tsai LH: Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 2000;405:360-364.
35. Wang X, Ching YP, Lam WH, Qi Z, Zhang M, Wang JH: Identification of a common protein association region in the neuronal Cdk5 activator. J Biol Chem 2000;275:31763-31769.
36. Cheng K, Li Z, Fu WY, Wang JH, Fu AK, Ip NY: Pctaire1 interacts with p35 and is a novel substrate for Cdk5/p35. J Biol Chem 2002;277:31988-31993.
37. Chin KT, Ohki SY, Tang D, Cheng HC, Wang JH, Zhang M: Identification and structure characterization of a Cdk inhibitory peptide derived from neuronal-specific Cdk5 activator. J Biol Chem 1999;274:7120-7127.
38. Tang D, Chun AC, Zhang M, Wang JH: Cyclin-dependent kinase 5 (Cdk5) activation domain of neuronal Cdk5 activator: Evidence of the existence of cyclin fold in neuronal Cdk5a activator. J Biol Chem 1997;272:12318-12327.
39. Chou KC, Watenpaugh KD, Heinrikson RL: A model of the complex between cyclin-dependent kinase 5 and the activation domain of neuronal Cdk5 activator. Biochem Biophys Res Commun 1999;259:420-428.
40. Lim HY, Seow KT, Li Q, Kesuma D, Wang JH, Qi RZ: Structural Insights into Cdk5 activation by a neuronal Cdk5 activator. Biochem Biophys Res Commun 2001;285:77-83.
41. Tarricone C, Dhavan R, Peng J, Areces LB, Tsai LH, Musacchio A: Structure and regulation of the CDK5-p25(nck5a) complex. Mol Cell 2001;8:657-669.
42. Mueller PR, Coleman TR, Kumagai A, Dunphy WG: Myt1: A membrane-associated inhibitory kinase that phosphorylates Cdc2 on both threonine-14 and tyrosine-15. Science 1995;270:86-90.
43. Mueller PR, Coleman TR, Dunphy WG: Cell cycle regulation of a Xenopus Wee1-like kinase. Mol Biol Cell 1995;6:119-134.
44. Watanabe N, Broome M, Hunter T: Regulation of the human WEE1Hu CDK tyrosine 15-kinase during the cell cycle. EMBO J 1995;14:1878-1891.
45. Gu Y, Rosenblatt J, Morgan DO: Cell cycle regulation of CDK2 activity by phosphorylation of Thr160 and Tyr15. EMBO J 1992;11:3995-4005.
46. Poon RY, Lew J, Hunter T: Identification of functional domains in the neuronal Cdk5 activator protein. J Biol Chem 1997;272:5703-5708.
47. Zukerberg LR, Patrick GN, Nikolic M, Humbert S, Wu CL, Lanier LM, Gertler FB, Vidal M, Van Etten RA, Tsai LH: Cables links Cdk5 and c-Abl and facilitates Cdk5 tyrosine phosphorylation, kinase upregulation, and neurite outgrowth. Neuron 2000;26:633-646.
48. Sasaki Y, Cheng C, Uchida Y, Nakajima O, Ohshima T, Yagi T, Taniguchi M, Nakayama T, Kishida R, Kudo Y, Ohno S, Nakamura F, Goshima Y: Fyn and Cdk5 mediate semaphorin-3A signaling, which is involved in regulation of dendrite orientation in cerebral cortex. Neuron 2002;35:907-920.
49. Kip1 in neurons. Proc Natl Acad Sci USA 1996;93:3259-3263.
50. Ching YP, Pang AS, Lam WH, Qi RZ, Wang JH: Identification of a neuronal Cdk5 activator-binding protein as Cdk5 inhibitor. J Biol Chem 2002;277:15237-15240.
51. Huang S, Jeffery DA, Anthony MD, O'Shea EK: Functional analysis of the cyclin-dependent kinase inhibitor Pho81 identifies a novel inhibitory domain. Mol Cell Biol 2001;21:6695-6705.
52. Moorthamer M, Zumstein-Mecker S, Chaudhuri B: DNA binding protein dbpA binds Cdk5 and inhibits its activity. FEBS Lett 1999;446:343-350.
53. Moorthamer M, Chaudhuri B: Identification of ribosomal protein L34 as a novel Cdk5 inhibitor. Biochem Biophys Res Commun 1999;255:631-638.
54. Nikolic M, Dudek H, Kwon YT, Ramos YF, Tsai LH: The cdk5/p35 kinase is essential for neurite outgrowth during neuronal differentiation. Genes Dev 1996;10:816-825.
55. Rashid T, Banerjee M, Nikolic M: Phosphorylation of Pak1 by the p35/Cdk5 kinase affects neuronal morphology. J Biol Chem 2001;276:49043-49052.
56. cdc2. J Biol Chem 1992;267:25922-25926.
57. Wada Y, Ishiguro K, Itoh TJ, Uchida T, Hotani H, Saito T, Kishimoto T, Hisanaga S: Microtubule-stimulated phosphorylation of tau at Ser202 and Thr205 by cdk5 decreases its microtubule nucleation activity. J Biochem (Tokyo) 1998;124:738-746.
58. Grant P, Sharma P, Pant HC: Cyclin-dependent protein kinase 5 (Cdk5) and the regulation of neurofilament metabolism. Eur J Biochem 2001;268:1534-1546.
59. Qi Z, Tang D, Zhu X, Fujita DJ, Wang JH: Association of neurofilament proteins with neuronal Cdk5 activator. J Biol Chem 1998;273:2329-2335.
60. Ishiguro K, Takamatsu M, Tomizawa K, Omori A, Takahashi M, Arioka M, Uchida T, Imahori K: Tau protein kinase I converts normal tau protein into A68-like component of paired helical filaments. J Biol Chem 1992;267:10897- 10901.
61. Sobue K, Agarwal-Mawal A, Li W, Sun W, Miura Y, Paudel HK: Interaction of neuronal Cdc2-like protein kinase with microtubule-associated protein tau. J Biol Chem 2000;275:16673-16680.
62. Liu Z, Steward R, Luo L: Drosophila Lis1 is required for neuroblast proliferation, dendritic elaboration and axonal transport. Nat Cell Biol 2000;2:776-783.
63. Humbert S, Lanier LM, Tsai LH: Synaptic localization of p39, a neuronal activator of cdk5. Neuroreport 2000;11:2213-2216.
64. Niethammer M, Smith DS, Ayala R, Peng J, Ko J, Lee MS, Morabito M, Tsai LH: NUDEL is a novel Cdk5 substrate that associates with LIS1 and cytoplasmic dynein. Neuron 2000;28:697-711.
65. Fletcher AI, Shuang R, Giovannucci DR, Zhang L, Bittner MA, Stuenkel EL: Regulation of exocytosis by cyclin-dependent kinase 5 via phosphorylation of Munc18. J Biol Chem 1999;274:4027-4035.
66. Matsubara M, Kusubata M, Ishiguro K, Uchida T, Titani K, Taniguchi H: Site-specific phosphorylation of synapsin I by mitogen-activated protein kinase and Cdk5 and its effects on physiological functions. J Biol Chem 1996;271:21108-21113.
67. Floyd SR, Porro EB, Slepnev VI, Ochoa GC, Tsai LH, De Camilli P: Amphiphysin 1 binds the cyclin-dependent kinase (cdk) 5 regulatory subunit p35 and is phosphorylated by cdk5 and cdc2. J Biol Chem 2001;276:8104-8110.
68. Shuang R, Zhang L, Fletcher A, Groblewski GE, Pevsner J, Stuenkel EL: Regulation of Munc-18/syntaxin 1A interaction by cyclin-dependent kinase 5 in nerve endings. J Biol Chem 1998;273:4957-4966.
69. Tan TC, Valova VA, Malladi CS, Graham ME, Berven LA, Jupp OJ, Hansra G, McClure SJ, Sarcevic B, Boadle RA, Larsen MR, Cousin MA, Robinson PJ: Cdk5 is essential for synaptic vesicle endocytosis. Nat Cell Biol 2003;5:701-710.
70. 2+/calmodulin-dependent protein kinase II and alpha-actinin-1 in a calcium-dependent manner. J Neurosci 2002;22:7879-7891.
71. Kwon YT, Gupta A, Zhou Y, Nikolic M, Tsai LH: Regulation of N-cadherin-mediated adhesion by the p35-Cdk5 kinase. Curr Biol 2000;10:363-372.
72. Kesavapany S, Lau KF, McLoughlin DM, Brownlees J, Ackerley S, Leigh PN, Shaw CE, Miller CC: p35/cdk5 binds and phosphorylates beta-catenin and regulates beta-catenin/presenilin-1 interaction. Eur J Neurosci 2001;13:241-247.
73. Bibb JA, Snyder GL, Nishi A, Yan Z, Meijer L, Fienberg AA, Tsai LH, Kwon YT, Girault JA, Czernik AJ, Huganir RL, Hemmings HC, Nairn AC, Greengard P: Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons. Nature 1999;402:669-671.
74. Greengard P, Allen PB, Nairn AC: Beyond the dopamine receptor: The DARPP-32/protein phosphatase-1 cascade. Neuron 1999;23:435-447.
75. Li BS, Zhang L, Takahashi S, Ma W, Jaffe H, Kulkarni AB, Pant HC: Cyclin-dependent kinase 5 prevents neuronal apoptosis by negative regulation of c-Jun N-terminal kinase 3. EMBO J 2002;21:324-333.
76. Sharma P, Veeranna Sharma M, Amin ND, Sihag RK, Grant P, Ahn N, Kulkarni AB, Pant HC: Phosphorylation of MEK1 by cdk5/p35 down-regulates the mitogen-activated protein kinase pathway. J Biol Chem 2002;277:528-534.
77. Tomizawa K, Ohta J, Matsushita M, Moriwaki A, Li ST, Takei K, Matsui H: Cdk5/p35 regulates neurotransmitter release through phosphorylation and downregulation of P/Q-type voltage-dependent calcium channel activity. J Neurosci 2002;22:2590-2597.
78. Li BS, Sun MK, Zhang L, Takahashi S, Ma W, Vinade L, Kulkarni AB, Brady RO, Pant HC: Regulation of NMDA receptors by cyclin-dependent kinase-5. Proc Natl Acad Sci USA 2001;98:12742-12747.
79. Lee KY, Helbing CC, Choi KS, Johnston RN, Wang JH: Neuronal Cdc2-like kinase (Nclk) binds and phosphorylates the retinoblastoma protein. J Biol Chem 1997;272:5622-5626.
80. Zhang J, Krishnamurthy PK, Johnson GV: Cdk5 phosphorylates p53 and regulates its activity. J Neurochem 2002;81:307-313.
81. Gong X, Tang X, Wiedmann M, Wang X, Peng J, Zheng D, Blair LA, Marshall J, Mao Z: Cdk5-mediated inhibition of the protective effects of transcription factor MEF2 in neurotoxicity-induced apoptosis. Neuron 2003;38:33-46.
82. Ching YP, Qi Z, Wang JH: Cloning of three novel neuronal Cdk5 activator binding proteins. Gene 2000;242:285-294.
83. Gavin AC, Bosche M, Krause R, et al: Functional organization of the yeast proteome by systematic analysis of protein complexes. Nature 2002;415:141-147.
84. Ho Y, Gruhler A, Heilbut A, et al: Systematic identification of protein complexes in Saccharomyces cerevisiaeby mass spectrometry. Nature 2002;415:180-183.
85. Patrick GN, Zhou P, Kwon YT, Howley PM, Tsai LH: p35, the neuronal-specific activator of cyclin-dependent kinase 5 (Cdk5), is degraded by the ubiquitin-proteasome pathway. J Biol Chem 1998;273:24057-24064.
86. Nikolic M, Chou MM, Lu W, Mayer BJ, Tsai LH: The p35/Cdk5 kinase is a neuron-specific Rac effector that inhibits Pak1 activity. Nature 1998;395:194-198.
87. Baumann K, Mandelkow EM, Biernat J, Piwnica-Worms H, Mandelkow E: Abnormal Alzheimer-like phosphorylation of tau-protein by cyclin-dependent kinases cdk2 and cdk5. FEBS Lett 1993;336:417-424.
88. Agarwal-Mawal A, Paudel HK: Neuronal Cdc2-like protein kinase (Cdk5/p25) is associated with protein phosphatase 1 and phosphorylates inhibitor-2. J Biol Chem 2001;276:23712-23718.
89. Bajaj NP, al-Sarraj ST, Anderson V, Kibble M, Leigh N, Miller CC: Cyclin-dependent kinase-5 is associated with lipofuscin in motor neurones in amyotrophic lateral sclerosis. Neurosci Lett 1998;245:45-48.
90. Fu AK, Fu WY, Cheung J, Tsim KW, Ip FC, Wang JH, Ip NY: Cdk5 is involved in neuregulin-induced AChR expression at the neuromuscular junction. Nat Neurosci 2001;4:374-381.
91. Chen J, Liu B, Liu Y, Han Y, Yu H, Zhang Y, Lu L, Zhen Y, Hui R: A novel gene IC53 stimulates ECV304 cell proliferation and is upregulated in failing heart. Biochem Biophys Res Commun 2002;294:161-166.
92. Xie YH, He XH, Tang YT, Li JJ, Pan ZM, Qin WX, Wan da F, Gu JR: Cloning and characterization of human IC53-2, a novel CDK5 activator binding protein. Cell Res 2003;13:83-91.
93. Sato H, Nishimoto I, Matsuoka M: ik3-2, a relative to ik3-1/cables, is associated with cdk3, cdk5, and c-abl. Biochim Biophys Acta 2002;1574:157-163.
94. Ackerley S, Thornhill P, Grierson AJ, Brownlees J, Anderton BH, Leigh PN, Shaw CE, Miller CC: Neurofilament heavy chain side arm phosphorylation regulates axonal transport of neurofilaments. J Cell Biol 2003;161:489-495.
95. Pigino G, Paglini G, Ulloa L, Avila J, Caceres A: Analysis of the expression, distribution and function of cyclin dependent kinase 5 (cdk5) in developing cerebellar macroneurons. J Cell Sci 1997;110:257-270.
96. Paglini G, Pigino G, Kunda P, Morfini G, Maccioni R, Quiroga S, Ferreira A, Caceres A: Evidence for the participation of the neuron-specific CDK5 activator p35 during laminin-enhanced axonal growth. J Neurosci 1998;18:9858-9869.
97. Kato G, Maeda S: Neuron-specific Cdk5 kinase is responsible for mitosis-independent phosphorylation of c-Src at Ser75 in human Y79 retinoblastoma cells. J Biochem (Tokyo) 1999;126:957-961.
98. Iijima K, Ando K, Takeda S, Satoh Y, Seki T, Itohara S, Greengard P, Kirino Y, Nairn AC, Suzuki T: Neuron-specific phosphorylation of Alzheimer's beta-amyloid precursor protein by cyclin-dependent kinase 5. J Neurochem 2000;75:1085-1091.
99. Lau KF, Howlett DR, Kesavapany S, Standen CL, Dingwall C, McLoughlin DM, Miller CC: Cyclin-dependent kinase-5/p35 phosphorylates presenilin 1 to regulate carboxy-terminal fragment stability. Mol Cell Neurosci 2002;20:13-20.
100. Lindskog M, Svenningsson P, Pozzi L, Kim Y, Fienberg AA, Bibb JA, Fredholm BB, Nairn AC, Greengard P, Fisone G: Involvement of DARPP-32 phosphorylation in the stimulant action of caffeine. Nature 2002;418:774-778.
101. Huang KX, Paudel HK: Ser67-phosphorylated inhibitor 1 is a potent protein phosphatase 1 inhibitor. Proc Natl Acad Sci USA 2000;97:5824-5829.
102. Keshvara L, Magdaleno S, Benhayon D, Curran T: Cyclin-dependent kinase 5 phosphorylates disabled 1 independently of Reelin signaling. J Neurosci 2002;22:4869-4877.
103. Hayashi F, Matsuura I, Kachi S, Maeda T, Yamamoto M, Fujii Y, Liu H, Yamazaki M, Usukura J, Yamazaki A: Phosphorylation by cyclin-dependent protein kinase 5 of the regulatory subunit of retinal cGMP phosphodiesterase. II. Its role in the turnoff of phosphodiesterase in vivo. J Biol Chem 2000;275:32958-32965.
104. Matsuura I, Bondarenko VA, Maeda T, Kachi S, Yamazaki M, Usukura J, Hayashi F, Yamazaki A: Phosphorylation by cyclin-dependent protein kinase 5 of the regulatory subunit of retinal cGMP phosphodiesterase. I. Identification of the kinase and its role in the turnoff of phosphodiesterase in vitro. J Biol Chem 2000;275:32950-32957.